RJ
James, Richard William
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports |  | 2021 | 260 | 181 | ||
| HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3 | PLOS ONE | | 2019 | 293 | 210 | ||
| High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate | European Journal of Clinical Investigation |  | 2018 | 500 | 0 | ||
| Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease | International Journal of Molecular Sciences | | 2018 | 615 | 247 | ||
| Pharmacological Intervention to Modulate HDL: What Do We Target? | Frontiers in Pharmacology | | 2017 | 500 | 441 | ||
| Self-Observation and Peer Feedback as a Faculty Development Approach for Problem-Based Learning Tutors: A Program Evaluation | Teaching and learning in medicine | | 2017 | 714 | 982 | ||
| Impaired stimulation of glucose transport in cardiac myocytes exposed to very low-density lipoproteins | NMCD. Nutrition Metabolism and Cardiovascular Diseases |  | 2016 | 535 | 3 | ||
| Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 | Cardiovascular research | | 2016 | 700 | 6 | ||
| Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection | Arteriosclerosis, Thrombosis, and Vascular Biology | | 2016 | 628 | 1 | ||
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | PloS one | | 2015 | 680 | 269 | ||
| Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling | Immunity, inflammation and disease | | 2015 | 1,196 | 218 | ||
| CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes | Endocrinology | | 2015 | 671 | 1 | ||
| Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system | Life sciences | | 2014 | 629 | 0 | ||
| Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects | Clinical biochemistry | | 2014 | 496 | 0 | ||
| High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways | Advances in experimental medicine and biology | 2014 | 552 | 0 | |||
| HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity | Atherosclerosis | | 2013 | 555 | 0 | ||
| HDLs protect pancreatic β-cells against ER stress by restoring protein folding and trafficking | Diabetes | | 2012 | 640 | 0 | ||
| Lack of association between connexin40 polymorphisms and coronary artery disease | Atherosclerosis | | 2012 | 600 | 5 | ||
| The natural cardioprotective particle HDL modulates connexin43 gap junction channels | Cardiovascular research | | 2012 | 679 | 4 | ||
| Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins | Current signal transduction therapy | 2012 | 574 | 0 | |||
| High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway | JAK-STAT | | 2012 | 620 | 372 | ||
| Consistency between cross-sectional and longitudinal SNP: blood lipid associations | European journal of epidemiology | | 2012 | 661 | 367 | ||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | | 2012 | 593 | 0 | ||
| Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channels | Endocrinology | | 2012 | 713 | 0 | ||
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | | 2011 | 640 | 0 | ||
| When are pro-inflammatory cytokines SAFE in heart failure? | European heart journal | | 2011 | 602 | 0 | ||
| HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress | Free radical biology & medicine | | 2011 | 694 | 679 | ||
| Paraoxonase-1 and clopidogrel efficacy | Nature medicine | | 2011 | 515 | 0 | ||
| Effects of paraoxonase activity and gene polymorphism on coronary vasomotion | EJNMMI research | | 2011 | 574 | 312 | ||
| The scavenger receptor class B, type I is a primary determinant of paraoxonase-1 association with high-density lipoproteins | Arteriosclerosis, thrombosis, and vascular biology | | 2010 | 586 | 0 | ||
| The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function | Advances in experimental medicine and biology | 2010 | 613 | 0 | |||
| Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis | Cardiovascular research | | 2010 | 601 | 0 | ||
| Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins | BMC immunology | | 2010 | 604 | 510 | ||
| Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes | Pharmacogenetics and genomics | | 2010 | 611 | 0 | ||
| Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice | Journal of Endocrinology | | 2010 | 935 | 0 | ||
| Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction | European heart journal | | 2010 | 710 | 0 | ||
| Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients | NMCD. Nutrition Metabolism and Cardiovascular Diseases | | 2009 | 647 | 0 | ||
| Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate | Cardiovascular research | | 2009 | 563 | 0 | ||
| Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism | Diabetes | | 2008 | 719 | 1 | ||
| Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome | Clinical science | | 2008 | 775 | 9 | ||
| Paraoxonase 1: genetics and activities during aging | Rejuvenation research | | 2008 | 613 | 0 | ||
| HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress | Journal of lipid research | | 2008 | 567 | 0 | ||
| Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? | Atherosclerosis | | 2007 | 641 | 0 | ||
| In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved | Journal of Clinical Epidemiology | | 2005 | 147 | 0 | ||
| Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease | Journal of autoimmunity | | 2004 | 544 | 0 | ||
| Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice | Circulation | | 2003 | 567 | 1 | ||
| Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I | Endocrinology | | 2001 | 705 | 484 | ||
| From biopsy to automatic diagnosis | Schweizerische medizinische Wochenschrift | 1990 | 561 | 0 |
